Clinical trial
Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis
NCT00111098 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00111098 |
|---|---|
| Title | Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis |
| Official title | A Multicenter, Single Arm Study Evaluating Once Monthly Darbepoetin Alfa Dosing In Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Disease |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa |
| Enrollment | 150 |
| Start date | Mar 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | May 18, 2005 |
| Last update posted | Aug 8, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: